234 related articles for article (PubMed ID: 21172019)
21. A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer.
Kendzia S; Franke S; Kröhler T; Golob-Schwarzl N; Schweiger C; Toeglhofer AM; Skofler C; Uranitsch S; El-Heliebi A; Fuchs J; Punschart A; Stiegler P; Keil M; Hoffmann J; Henderson D; Lehrach H; Yaspo ML; Reinhard C; Schäfer R; Keilholz U; Regenbrecht C; Schicho R; Fickert P; Lax SF; Erdmann F; Schulz MH; Kiemer AK; Haybaeck J; Kessler SM
Mol Cancer; 2023 May; 22(1):89. PubMed ID: 37248468
[TBL] [Abstract][Full Text] [Related]
22. Identification of differentially expressed sense and antisense transcript pairs in breast epithelial tissues.
Grigoriadis A; Oliver GR; Tanney A; Kendrick H; Smalley MJ; Jat P; Neville AM
BMC Genomics; 2009 Jul; 10():324. PubMed ID: 19615061
[TBL] [Abstract][Full Text] [Related]
23. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
24. Molecular profile of 5-fluorouracil pathway genes in colorectal carcinoma.
Kunicka T; Prochazka P; Krus I; Bendova P; Protivova M; Susova S; Hlavac V; Liska V; Novak P; Schneiderova M; Pitule P; Bruha J; Vycital O; Vodicka P; Soucek P
BMC Cancer; 2016 Oct; 16(1):795. PubMed ID: 27733154
[TBL] [Abstract][Full Text] [Related]
25. Serum miR-19a predicts resistance to FOLFOX chemotherapy in advanced colorectal cancer cases.
Chen Q; Xia HW; Ge XJ; Zhang YC; Tang QL; Bi F
Asian Pac J Cancer Prev; 2013; 14(12):7421-6. PubMed ID: 24460313
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
Vishnubalaji R; Hamam R; Yue S; Al-Obeed O; Kassem M; Liu FF; Aldahmash A; Alajez NM
Oncotarget; 2016 Jun; 7(24):35789-35802. PubMed ID: 27119506
[TBL] [Abstract][Full Text] [Related]
27. Microarray Analysis of Circular RNA Expression Profile Associated with 5-Fluorouracil-Based Chemoradiation Resistance in Colorectal Cancer Cells.
Xiong W; Ai YQ; Li YF; Ye Q; Chen ZT; Qin JY; Liu QY; Wang H; Ju YH; Li WH; Li YF
Biomed Res Int; 2017; 2017():8421614. PubMed ID: 28656150
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
[No Abstract] [Full Text] [Related]
29. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
[TBL] [Abstract][Full Text] [Related]
30. Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer.
Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Cortesini C; Mazzei T; Mini E
Int J Cancer; 2011 Apr; 128(8):1935-45. PubMed ID: 20560137
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of miR-215-3p sensitizes colorectal cancer to 5-fluorouracil induced apoptosis through regulating CXCR1.
Li XW; Qiu SJ; Zhang X
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7240-7250. PubMed ID: 30468467
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA expression patterns in lymph node metastasis in colorectal cancer by microarray.
Rui Q; Xu Z; Yang P; He Z
Biomed Pharmacother; 2015 Oct; 75():12-8. PubMed ID: 26463626
[TBL] [Abstract][Full Text] [Related]
34. Alternative expression analysis by RNA sequencing.
Griffith M; Griffith OL; Mwenifumbo J; Goya R; Morrissy AS; Morin RD; Corbett R; Tang MJ; Hou YC; Pugh TJ; Robertson G; Chittaranjan S; Ally A; Asano JK; Chan SY; Li HI; McDonald H; Teague K; Zhao Y; Zeng T; Delaney A; Hirst M; Morin GB; Jones SJ; Tai IT; Marra MA
Nat Methods; 2010 Oct; 7(10):843-7. PubMed ID: 20835245
[TBL] [Abstract][Full Text] [Related]
35. RHBDD2: a 5-fluorouracil responsive gene overexpressed in the advanced stages of colorectal cancer.
Lacunza E; Canzoneri R; Rabassa ME; Zwenger A; Segal-Eiras A; Croce MV; Abba MC
Tumour Biol; 2012 Dec; 33(6):2393-9. PubMed ID: 22965880
[TBL] [Abstract][Full Text] [Related]
36. CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis.
Lai Q; Li Q; He C; Fang Y; Lin S; Cai J; Ding J; Zhong Q; Zhang Y; Wu C; Wang X; He J; Liu Y; Yan Q; Li A; Liu S
Aging (Albany NY); 2020 Jul; 12(16):16270-16293. PubMed ID: 32688344
[TBL] [Abstract][Full Text] [Related]
37. Induced miR-31 by 5-fluorouracil exposure contributes to the resistance in colorectal tumors.
Nakagawa Y; Kuranaga Y; Tahara T; Yamashita H; Shibata T; Nagasaka M; Funasaka K; Ohmiya N; Akao Y
Cancer Sci; 2019 Aug; 110(8):2540-2548. PubMed ID: 31162779
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
Bianchini M; Levy E; Zucchini C; Pinski V; Macagno C; De Sanctis P; Valvassori L; Carinci P; Mordoh J
Int J Oncol; 2006 Jul; 29(1):83-94. PubMed ID: 16773188
[TBL] [Abstract][Full Text] [Related]
39. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
40. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
